Dataset Information


A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS.

ABSTRACT: Amyotrophic lateral sclerosis (ALS) is a rapidly progressing neurodegenerative disease, characterized by motor neuron (MN) death, for which there are no truly effective treatments. Here, we describe a new small molecule survival screen carried out using MNs from both wild-type and mutant SOD1 mouse embryonic stem cells. Among the hits we found, kenpaullone had a particularly impressive ability to prolong the healthy survival of both types of MNs that can be attributed to its dual inhibition of GSK-3 and HGK kinases. Furthermore, kenpaullone also strongly improved the survival of human MNs derived from ALS-patient-induced pluripotent stem cells and was more active than either of two compounds, olesoxime and dexpramipexole, that recently failed in ALS clinical trials. Our studies demonstrate the value of a stem cell approach to drug discovery and point to a new paradigm for identification and preclinical testing of future ALS therapeutics.


PROVIDER: S-EPMC3707511 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC4230530 | BioStudies
2019-01-01 | S-EPMC6921360 | BioStudies
2014-01-01 | S-EPMC3951532 | BioStudies
2006-01-01 | S-EPMC6674380 | BioStudies
2018-01-01 | S-EPMC5964114 | BioStudies
1000-01-01 | S-EPMC3480575 | BioStudies
2019-01-01 | S-EPMC6549675 | BioStudies
2016-01-01 | S-EPMC4893611 | BioStudies
2014-01-01 | S-EPMC4272269 | BioStudies
2020-01-01 | S-EPMC7710664 | BioStudies